Goldman Sachs Group Inc. lowered its position in shares of OraSure Technologies, Inc. (NASDAQ:OSUR - Free Report) by 53.0% in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 275,279 shares of the medical instruments supplier's stock after selling 310,012 shares during the quarter. Goldman Sachs Group Inc. owned approximately 0.37% of OraSure Technologies worth $928,000 as of its most recent SEC filing.
A number of other hedge funds have also made changes to their positions in OSUR. Ameriprise Financial Inc. raised its holdings in shares of OraSure Technologies by 65.1% during the fourth quarter. Ameriprise Financial Inc. now owns 173,989 shares of the medical instruments supplier's stock valued at $628,000 after acquiring an additional 68,629 shares during the last quarter. Deutsche Bank AG raised its holdings in shares of OraSure Technologies by 68.5% during the fourth quarter. Deutsche Bank AG now owns 72,672 shares of the medical instruments supplier's stock valued at $262,000 after acquiring an additional 29,545 shares during the last quarter. Millennium Management LLC raised its holdings in shares of OraSure Technologies by 16.7% during the fourth quarter. Millennium Management LLC now owns 2,158,450 shares of the medical instruments supplier's stock valued at $7,792,000 after acquiring an additional 308,420 shares during the last quarter. ProShare Advisors LLC raised its holdings in shares of OraSure Technologies by 49.0% during the fourth quarter. ProShare Advisors LLC now owns 20,327 shares of the medical instruments supplier's stock valued at $73,000 after acquiring an additional 6,689 shares during the last quarter. Finally, Two Sigma Investments LP acquired a new position in shares of OraSure Technologies during the fourth quarter valued at approximately $552,000. Institutional investors and hedge funds own 93.50% of the company's stock.
OraSure Technologies Price Performance
OSUR stock opened at $3.32 on Tuesday. The business has a 50 day simple moving average of $3.15 and a 200-day simple moving average of $3.05. The firm has a market capitalization of $242.82 million, a PE ratio of -4.96 and a beta of 0.44. OraSure Technologies, Inc. has a 1 year low of $2.36 and a 1 year high of $4.60.
About OraSure Technologies
(
Free Report)
OraSure Technologies, Inc, together with its subsidiaries, provides point-of-care and home diagnostic tests, specimen collection devices, and microbiome laboratory and analytical services in the United States, Europe, and internationally. The company's products include InteliSwab COVID-19 rapid test, InteliSwab COVID-19 rapid test pro, InteliSwab COVID-19 rapid test rx, OraQuick Rapid HIV test, OraQuick In-Home HIV test, OraQuick HIV self-test, OraQuick HCV rapid antibody test, OraQuick Ebola rapid antigen test, OraSure oral fluid collection device used in conjunction with screening and confirmatory tests for HIV-1 antibodies; Intercept drug testing systems; immunoassay tests and reagents; and Q.E.D.
Featured Stories
Want to see what other hedge funds are holding OSUR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for OraSure Technologies, Inc. (NASDAQ:OSUR - Free Report).
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider OraSure Technologies, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and OraSure Technologies wasn't on the list.
While OraSure Technologies currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
